Citigroup’s Foundation Medicine, Inc. FMI Stock Holding History

Citigroup’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,000	Closed	-$1.09M	–	7990
2018 Q2	$1.09M	Sell	8,000 -1,900	-19%	-$173K	﹤0.01%	3268
2018 Q1	$780K	Buy	9,900 +6,200	+168%	+$457K	﹤0.01%	3505
2017 Q4	$252K	Buy	+3,700	New	+$192K	﹤0.01%	4831
2017 Q3	–	Sell	-4,500	Closed	-$179K	–	7592
2017 Q2	$179K	Buy	4,500 +1,700	+61%	+$62.2K	﹤0.01%	4903
2017 Q1	$90K	Hold	2,800	–	–	﹤0.01%	5285
2016 Q4	$50K	Buy	+2,800	New	+$60.3K	﹤0.01%	6146

Citigroup's FMI Position: Q3 2018 in Review

Citigroup sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 173,037 shares — an estimated $23.7M sold.

Citigroup first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $23.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Citigroup reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Citigroup sold 173,037 Foundation Medicine, Inc. shares in Q3 2018, an estimated $23.7M.
Citigroup first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
Citigroup's Foundation Medicine, Inc. position peaked at $23.7M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.